India's first dengue vaccine approved India's drug regulatory authority has approved the Kydenga vaccine against dengue for use. The dengue vaccine has been approved in India. The vaccine named Kydenga, developed by a Japanese company against the dengue virus, has been approved for use in India. Developed by Japanese pharmaceutical company Takeda Pharmaceuticals , this vaccine has been approved by India's drug regulatory authority Central Drug Standards and Organization (CDACO). The Kydenga vaccine is said to provide protection against all four types of dengue virus serotypes 1, 2, 3 and 4 . Like the COVID-19 vaccine , it requires two doses. The second dose should be given three months after the first dose. This vaccine, which can be given to people aged 4 to 60 years, can also be given to those who have not had dengue. This vaccine, which is currently being produced in India, currently costs between Rs 6,000 and Rs 12,000 per dose . The price is expected to come down in ...
Breast cancer can happen to women of any age Breast cancer is a cancer that occurs in the cells of the breast. This type of cancer is now spreading rapidly in Nepal as well. Breast cancer is the most common cancer in women. The number of breast cancer cases has been increasing in Nepal for the past few years. Generally, breast cancer is more common in women aged 40 to 50 years. But now it is also seen in women aged 25 to 45 years. Not only that, some cases have also been seen in the age group above 20 years. Breast cancer is the most common cancer in European countries. In Asian countries, it was less visible than in Europe. But recently, the number of breast cancer is also increasing in Asian countries. According to the latest data, one out of six women has breast cancer. Reasons why cancer appears at a young age The main cause of breast cancer is genetics. But the reason why cancer appears at a young age is the change in our lifestyle and diet. For some years we have adopted a w...